Skip to main content
. 2010 Mar 25;3(4):348–366.

Table 4.

Association between ARC-subCLST and pathobiological features

Cluster A1 A2 B C1 C2 D
Stage I [191] [36] [42] [23] [41] [25] [20]
Size [mean ± SD mm] [24.8 ± 16.7 (7.0 to 120.0)] (Student's test, p < 0.0100: [A1,A2] vs [D])
19.3 ± 7.6 21.6 ± 13.8 26.4 ± 15.1 26.5 ± 19.2 26.7 ±17.7 35.2 ± 23.5
Pleural invasion (Fisher's exact test, p = 0.0002)
0 [158] 36 [100.0%] 41 [97.6%] 17 [74.0%] 29 [70.7%] 18 [72.0%] 18 [72.0%]
1[23] 0 [0.0%] 1 [2.4%] 3 [13.0%] 9 [22.0%] 7 [28.0%] 2 [22.0%]
2 [10] 0 [0.0%] 0 [0.0%] 3 [13.0%] 3 [7.3%] 0 [0.0%] 4 [20.0%]
Lymphatic canal involvement (Fisher's exact test, p < 0.0001)
0[61] 12 [33.3%] 31 [73.8%] 8 [34.8%] 6 [14.6%] 2 [8.0%] 2 [10.0%]
1 [110] 23 [63.9%] 11 [26.2%] 13 [56.5%] 31 [75.6%] 19 [76.0%] 11 [55.0%]
2 [18] 1 [2.8%] 0 [0.0%] 2 [8.7%] 4 [9.8%] 4 [16.0%] 5 [25.0%]
3 [2] 0 [0.0%] 0 [0.0%] 0 [0.0%] 0 [0.0%] 0 [0.0%] 2 [10.0%]
Vascular involvement (Fisher's exact test, p < 0.0001)
0 [129] 29 [80.6%] 41 [97.6%] 13 [56.5%] 28 [68.3%] 10 [40.0%] 6 [30.0%]
1[46] 6 [16.7%] 0 [0.0%] 8 [34.8%] 12 [29.3%] 11 [44.4%] 7 [35.0%]
2 [14] 1 [2.7%] 1 [2.4%] 2 [8.7%] 1 [2.4%] 4 [16.0%] 5 [25.0%]
3 [2] 0 [0.0%] 0 [0.0%] 0 [0.0%] 0 [0.0%] 0 [0.0%] 2 [10.0%]
Grwoth activity [MIB1 index, mean ± SD %] [15.4 ± 17.5 (0.1 to 80.7)] (Student's t test, p < 0.0001: [A1,A2] vs [C2,D])
7.6 ± 12.7 4.4 ± 8.7 11.8 ± 13.0 15.1 ± 13.2 31.2 ± 21.1 33.5 ± 15.8
Stage IA [133] [32] [133] [29] [29] [16] [8]
Size [mean ± SD mm] [19.3 ± 7.6 (7.0 to 30.0)] (Student's t test, no significant difference)
18.0 ± 6.7 15.7 ± 6.8 16.7 ± 7.7 18.0 ± 6.2 16.8 ± 4.9 14.8 ± 5.6
Pleural invasion (Fisher's exact test, p = 0.0188)
0 [122] 32 [100.0%] 33 [100.0%] 10 [83.3%] 24 [82.8%] 13 [81.3%] 8 [100.0%]
1[11] 0 [0.0%] 0 [0.0%] 2 [16.7%] 5 [17.2%] 3 [18.7%] 0 [0.0%]
Lymphatic canal involvement (Fisher's exact test, p < 0.0001)
0[52] 11 [34.4%] 28 [84.8%] 5 [36.4%] 5 [17.2%] 2 [12.5%] 1 [12.5%]
1[74] 21 [65.6%] 5 [15.2%] 7 [63.6%] 23 [79.4%] 12 [75.0%] 4 [50.0%]
2 [6] 0 [0.0%] 0 [0.0%] 0 [0.0%] 1 [3.4%] 2 [12.5%] 2 [25.0%]
3[1] 0 [0.0%] 0 [0.0%] 0 [0.0%] 0 [0.0%] 0 [0.0%] 1 [12.5%]
Vascular involvement (Fisher's exact test, not suitable for analysis)
0[99] 26 [81.3%] 33 [100.0%] 7 [58.3%] 22 [75.9%] 7 [43.8%] 3 [37.5%]
1[29] 6 [18.7%] 0 [0.0%] 4 [33.3%] 7 [24.1%] 8 [50.0%] 2 [25.0%]
2 [5] 0 [0.0%] 0 [0.0%] 1 [8.4%] 0 [0.0%] 1 [6.3%] 3 [37.5%]
3[0] 0 [0.0%] 0 [0.0%] 0 [0.0%] 0 [0.0%] 0 [0.0%] 0 [0.0%]
Growth activity [MIB1 index, mean ± SD %] [12.4 ± 15.4 (0 to 66.1)] (Student's t test, p < 0.0010: [A1,A2] vs [C2,D])
7.2 ± 13.4 4.4 ± 9.7 9.1 ±14.3 13.0 ± 12.1 26.3 ± 14.8 27.5 ± 13.6
Stage IB [58] [4] [9] [11] [12] [9] [12]
Size [mean ± SD mm] [43.2 ± 18.5 (10.0 to 120.0)] (Student's t test, no significant difference)
30.0 ± 6.8 40.5 ± 13.7 35.1 ± 15.0 47.0 ±27.0 44.4 ± 18.5 48.9 ± 20.5
Pleural invasion (Fisher's exact test, p = 0.1715)
0[34] 4 [100.0%] 5 [55.6%] 8 [72.7%] 5 [41.7%] 5 [55.6%] 6 [50.0%]
1[15] 0 [0.0%] 4 [44.4%] 1 [9.1%] 4 [33.3%] 4 [44.4%] 2 [16.7%]
2 [9] 0 [0.0%] 0 [0.0%] 2 [18.2%] 3 [25.0%] 0 [0.0%] 4 [33.3%]
Lymphatic canal involvement (Fisher's exact test, p = 0.5434)
0[11] 1 [25.0%] 4 [44.4%] 3 [27.3%] 1 [8.3%] 0 [0.0%] 1 [8.3%]
1[35] 2 [50.0%] 5 [55.6%] 6 [54.5%] 8 [66.7%] 7 [77.8%] 7 [58.4%]
2 [11] 1 [25.0%] 0 [0.0%] 2 [18.2%] 3 [25.0%] 2 [22.2%] 3 [25.0%]
3[1] 0 [0.0%] 0 [0.0%] 0 [0.0%] 0 [0.0%] 0 [0.0%] 1 [8.3%]
Vascular involvement (Fisher's exact test, p = 0.0547)
0[31] 3 [75.0%] 9 [100.0%] 6 [54.5%] 6 [50.0%] 3 [33.3%] 3 [25.0%]
1[17] 0 [0.0%] 0 [0.0%] 4 [36.4%] 5 [41.7%] 3 [33.3%] 5 [41.6%]
2 [8] 1 [25.0%] 0 [0.0%] 1 [9.1%] 1 [8.3%] 3 [33.3%] 2 [16.7%]
3 [2] 0 [0.0%] 0 [0.0%] 0 [0.0%] 0 [0.0%] 0 [0.0%] 2 [16.7%]
Growth activity [MIB1 index, mean ± SD %] [20.1 ± 26.0 (0.1 to 80.7)] (Student's t test, p < 0.0100: [A1,A2] vs [D])
10.8 ± 5.1 4.5 ±4.2 14.3 ± 11.7 20.0 ± 14.8 39.7 ± 28.2 37.5 ± 16.4

ARC-subCLST, sub-clusters based on architectural element; SD, standard deviation; NA, not available.